
Quarterly organic sales rose 7.7%, while reported diluted earnings per share fell; Stryker updated its full-year outlook.
Stryker reported third-quarter net sales of $6.5 billion, up 7.7% from a year earlier. Organic sales also rose 7.7%, primarily on higher unit volume.
Reported diluted earnings per share fell 11.7% to $1.96. Adjusted diluted earnings per share increased 10.3% to $3.52, while adjusted operating margin rose to 26.2% from 25.6%.
Chief Executive Kevin A. Lobo said results reflected good overall performance but fell short of expectations. He said the company expects solid performance in the fourth quarter and momentum heading into 2027.
Stryker updated its 2026 outlook, forecasting organic sales growth of 6.5% to 7.0% and adjusted diluted earnings per share of $14.80 to $14.90.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.